Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Nuclear Medicine Review is Scopus-indexed (Q3, CiteScore 1.4), WoS ESCI, DOAJ. Published by Via Medica.
Checked against the index lists dated .
ISSN 1506-9680Verify ISSN ↗1644-4345Verify ISSN ↗
Publisher: Via Medica
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Radiology, Nuclear Medicine and Imaging | 254 / 361 | 29th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2002–present, best quartile Q3, CiteScore 1.4.
Nuclear Medicine Review is Q3 in Radiology, Nuclear Medicine and Imaging (rank 254 of 361), by CiteScore 2025.
Nuclear Medicine Review is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.4, which places it in quartile Q3 at the 29th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.281, quartile Q3, with an H-index of 28.
Nuclear Medicine Review is published by Via Medica. Its print ISSN is 1506-9680 and its online ISSN is 1644-4345.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Nuclear Medicine Review has an h-index of 22 and a 2-year mean of 0.37 citations per paper (OpenAlex). Its Scopus CiteScore is 1.4, quartile Q3. On 2-year citations it ranks #279 of 346 Scopus journals in Radiology, Nuclear Medicine and Imaging.
Nuclear Medicine Review published 26 papers in 2025; its busiest recent year was 2022 with 41. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 93 research articles (2022–2026), authors are most often from Poland (34.4%), Iran (14%) and Morocco (5.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.